EnBio Co. Ltd.
Enbio Co., Ltd. produces and sells pesticides in South Korea. It offers fungi-insecticides, fungicides, insecticides, herbicides, plant growth regulars, and fertilizers. The company was founded in 1997 and is headquartered in Gunpo-si, South Korea.
EnBio Co. Ltd. (352940) - Net Assets
Latest net assets as of June 2025: ₩43.97 Billion KRW
Based on the latest financial reports, EnBio Co. Ltd. (352940) has net assets worth ₩43.97 Billion KRW as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩69.90 Billion) and total liabilities (₩25.93 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩43.97 Billion |
| % of Total Assets | 62.91% |
| Annual Growth Rate | 36.06% |
| 5-Year Change | 11.96% |
| 10-Year Change | N/A |
| Growth Volatility | 65.55 |
EnBio Co. Ltd. - Net Assets Trend (2017–2024)
This chart illustrates how EnBio Co. Ltd.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for EnBio Co. Ltd. (2017–2024)
The table below shows the annual net assets of EnBio Co. Ltd. from 2017 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ₩41.37 Billion | +1.59% |
| 2023-12-31 | ₩40.73 Billion | -12.40% |
| 2022-12-31 | ₩46.49 Billion | -6.87% |
| 2021-12-31 | ₩49.92 Billion | +35.07% |
| 2020-12-31 | ₩36.95 Billion | +30.72% |
| 2019-12-31 | ₩28.27 Billion | +1089.65% |
| 2018-12-31 | ₩-2.86 Billion | -159.62% |
| 2017-12-31 | ₩4.79 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to EnBio Co. Ltd.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 418.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | ₩5.43 Billion | 13.13% |
| Other Components | ₩47.63 Billion | 115.13% |
| Total Equity | ₩41.37 Billion | 100.00% |
EnBio Co. Ltd. Competitors by Market Cap
The table below lists competitors of EnBio Co. Ltd. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Andromeda Metals Limited
PINK:ANDMF
|
$10.20 Million |
|
Aqua Corporation Public Company Limited
BK:AQUA
|
$10.21 Million |
|
HANHUA FNCL HLDG CO.H YC1
F:5HF
|
$10.21 Million |
|
Santa Fe Minerals Ltd
AU:SFM
|
$10.22 Million |
|
AIM Commercial Growth Freehold And Leasehold Real Estate Investment Trust
BK:AIMCG
|
$10.20 Million |
|
Mason Capital Corporation
KQ:021880
|
$10.20 Million |
|
Veranda Resort Public Company Limited
BK:VRANDA
|
$10.19 Million |
|
Bioray Biotech Co., Ltd
TWO:7561
|
$10.19 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in EnBio Co. Ltd.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 40,726,109,950 to 41,371,723,710, a change of 645,613,760 (1.6%).
- Net income of 645,613,760 contributed positively to equity growth.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩645.61 Million | +1.56% |
| Total Change | ₩- | 1.59% |
Book Value vs Market Value Analysis
This analysis compares EnBio Co. Ltd.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.52x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 3.44x to 0.52x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | ₩576.87 | ₩1984.00 | x |
| 2018-12-31 | ₩-343.94 | ₩1984.00 | x |
| 2019-12-31 | ₩3363.28 | ₩1984.00 | x |
| 2020-12-31 | ₩3664.46 | ₩1984.00 | x |
| 2021-12-31 | ₩4592.98 | ₩1984.00 | x |
| 2022-12-31 | ₩4277.66 | ₩1984.00 | x |
| 2023-12-31 | ₩3747.43 | ₩1984.00 | x |
| 2024-12-31 | ₩3806.84 | ₩1984.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently EnBio Co. Ltd. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 1.56%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 1.81%
- • Asset Turnover: 0.53x
- • Equity Multiplier: 1.64x
- Recent ROE (1.56%) is above the historical average (-0.08%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | 18.58% | 2.92% | 0.61x | 10.48x | ₩410.98 Million |
| 2018 | 0.00% | -26.69% | 0.54x | 0.00x | ₩-7.81 Billion |
| 2019 | 3.61% | 3.02% | 0.54x | 2.20x | ₩-1.81 Billion |
| 2020 | -12.04% | -12.87% | 0.48x | 1.93x | ₩-8.14 Billion |
| 2021 | 10.51% | 15.67% | 0.37x | 1.82x | ₩253.52 Million |
| 2022 | -7.41% | -10.06% | 0.39x | 1.88x | ₩-8.09 Billion |
| 2023 | -15.47% | -18.52% | 0.51x | 1.63x | ₩-10.37 Billion |
| 2024 | 1.56% | 1.81% | 0.53x | 1.64x | ₩-3.49 Billion |
Industry Comparison
This section compares EnBio Co. Ltd.'s net assets metrics with peer companies in the Waste Management industry.
Industry Context
- Industry: Waste Management
- Average net assets among peers: $71,001,424,727
- Average return on equity (ROE) among peers: 3.14%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| EnBio Co. Ltd. (352940) | ₩43.97 Billion | 18.58% | 0.59x | $10.20 Million |
| E& Corporation CO. LTD (066980) | $104.31 Billion | 0.96% | 0.93x | $24.87 Million |
| SebitChem Co. Ltd. (107600) | $63.15 Billion | 12.20% | 0.42x | $38.95 Million |
| ENVIONEER Co.Ltd (317870) | $45.55 Billion | -3.74% | 0.42x | $31.50 Million |